Laboratory Cross-Comparison and Ring Test Trial for Tumor

BRCA mutations BRCA testing NGS Ring Test Trial ovarian cancer

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
04 Nov 2022
Historique:
received: 26 09 2022
revised: 28 10 2022
accepted: 02 11 2022
entrez: 29 12 2022
pubmed: 30 12 2022
medline: 30 12 2022
Statut: epublish

Résumé

Germline and tumor

Identifiants

pubmed: 36579549
pii: jpm12111842
doi: 10.3390/jpm12111842
pmc: PMC9698073
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Astra Zéneca Farmacéutica Spain SA
ID : GEICO60-0

Références

J Clin Oncol. 2012 Jul 20;30(21):2654-63
pubmed: 22711857
Hum Mutat. 2012 Jan;33(1):2-7
pubmed: 21990146
Hum Mutat. 2017 Feb;38(2):226-235
pubmed: 27767231
J Pers Med. 2021 Jun 24;11(7):
pubmed: 34202525
J Mol Diagn. 2018 Sep;20(5):600-611
pubmed: 29936257
Clin Cancer Res. 2017 Aug 1;23(15):4086-4094
pubmed: 28223274
Cancers (Basel). 2019 Oct 24;11(11):
pubmed: 31653094
Gynecol Oncol. 2012 Jun;125(3):677-82
pubmed: 22406760
N Engl J Med. 1997 Apr 17;336(16):1125-30
pubmed: 9099656
Lancet Oncol. 2016 Nov;17(11):1579-1589
pubmed: 27617661
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
J Clin Oncol. 2010 Aug 1;28(22):3570-6
pubmed: 20606085
Oncotarget. 2016 Jan 12;7(2):1076-83
pubmed: 26745875
J Clin Oncol. 2020 Apr 10;38(11):1222-1245
pubmed: 31986064
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
PLoS Comput Biol. 2013 Apr;9(4):e1003031
pubmed: 23592973
Clin Cancer Res. 2014 Feb 1;20(3):764-75
pubmed: 24240112
Cancers (Basel). 2020 Nov 21;12(11):
pubmed: 33233347
Am J Obstet Gynecol. 2017 Sep;217(3):334.e1-334.e9
pubmed: 28549976
Cancers (Basel). 2022 Feb 27;14(5):
pubmed: 35267543
Mod Pathol. 2012 May;25(5):740-50
pubmed: 22282309
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Cancers (Basel). 2021 Aug 27;13(17):
pubmed: 34503154
JAMA. 2011 Oct 12;306(14):1557-65
pubmed: 21990299
J Mol Diagn. 2017 Jan;19(1):4-23
pubmed: 27993330
J Natl Cancer Inst. 2020 Feb 1;112(2):161-169
pubmed: 31076742
BMC Genomics. 2014 Jun 24;15:516
pubmed: 24962530
JAMA Oncol. 2016 Apr;2(4):482-90
pubmed: 26720728
Ann Oncol. 2022 Mar;33(3):276-287
pubmed: 34861371
Int J Cancer. 2022 Nov 1;151(9):1535-1541
pubmed: 35322413
Gynecol Oncol. 2011 May 1;121(2):353-7
pubmed: 21324516
Cancers (Basel). 2022 Mar 10;14(6):
pubmed: 35326583
Semin Oncol. 2017 Jun;44(3):187-197
pubmed: 29248130
Hum Mutat. 2018 Mar;39(3):394-405
pubmed: 29215764
Virchows Arch. 2020 Feb;476(2):195-207
pubmed: 31797087

Auteurs

Zaida Garcia-Casado (Z)

Molecular Biology Department, Fundacion Instituto Valenciano de Oncologia, 46009 Valencia, Spain.

Ana Oaknin (A)

Medical Oncology Department, Vall d'Hebron Instituto de Oncologia, 08035 Barcelona, Spain.

Marta Mendiola (M)

Instituto de Investigacion Biomedica del Hospital La Paz (IdiPAZ), 28029 Madrid, Spain.
Centro de Investigacion Biomedica en Red de Cáncer (CIBERONC) Instituto de Salud Carlos III, 28029 Madrid, Spain.

Gorka Alkorta-Aranburu (G)

CIMA LAB Diagnostics/Universidad de Navarra, 31008 Pamplona, Spain.

Jose Ramon Antunez-Lopez (JR)

Molecular Biology Department, Hospital Clinico Universitario Santiago, 15706 Santiago, Spain.

Gema Moreno-Bueno (G)

Centro de Investigacion Biomedica en Red de Cáncer (CIBERONC) Instituto de Salud Carlos III, 28029 Madrid, Spain.
Fundacion MD Anderson, 28033 Madrid, Spain.
Departamento de Bioquímica, Instituto de Investigaciones Biomedicas 'Alberto Sols. Conexion Cancer (UAM-CSIC), Universidad Autonoma de Madrid (UAM), IdiPAZ, 28029 Madrid, Spain.

Jose Palacios (J)

Centro de Investigacion Biomedica en Red de Cáncer (CIBERONC) Instituto de Salud Carlos III, 28029 Madrid, Spain.
Pathology Department, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.
Faculty of Medicine, Alcala University, 28801 Madrid, Spain.
Instituto Ramon y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain.

Alfonso Yubero (A)

Medical Oncology Department, Hospital Clinico Universitario Lozano Blesa, 50009 Zaragoza, Spain.

Raul Marquez (R)

Fundacion MD Anderson, 28033 Madrid, Spain.

Alejandro Gallego (A)

Medical Oncology Department, Hospital Universitario La Paz, 28029 Madrid, Spain.

Ana Beatriz Sanchez-Heras (AB)

Medical Oncology Department, Hospital General Universitario de Elche, 03203 Elche, Spain.

Jose Antonio Lopez-Guerrero (JA)

Molecular Biology Department, Fundacion Instituto Valenciano de Oncologia, 46009 Valencia, Spain.
Universidad Catolica de Valencia, 46001 Valencia, Spain.
Unidad Mixta de Investigacion en Cancer IVO-CIPF, 46009 Valencia, Spain.

Cristina Perez-Segura (C)

Medical Oncology Department, Hospital de Sant Pau i Santa Tecla, 43003 Tarragona, Spain.

Pilar Barretina-Ginesta (P)

Medical Oncology Department, Institut Catala d'Oncologia Girona, 17007 Girona, Spain.

Jesus Alarcon (J)

Medical Oncology Department, Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain.

Lydia Gaba (L)

Medical Oncology Department, Hospital Clinic de Barcelona, 08036 Barcelona, Spain.

Antonia Marquez (A)

Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, 29010 Malaga, Spain.

Judit Matito (J)

Cancer Genomics Lab, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.

Juan Cueva (J)

Medical Oncology Department, Hospital Clinico Universitario Santiago, 15706 Santiago, Spain.

Isabel Palacio (I)

Medical Oncology Department, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.

Maria Iglesias (M)

Medical Oncology Department, Hospital Universitario Son LLatzer, 07198 Palma de Mallorca, Spain.

Angels Arcusa (A)

Medical Oncology Department, Hospital de Terrassa, 08227 Terrassa, Spain.

Luisa Sanchez-Lorenzo (L)

Medical Oncology Department, Clinica Universidad de Navarra, 31008 Pamplona, Spain.

Eva Guerra-Alia (E)

Medical Oncology Department, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.

Ignacio Romero (I)

Medical Oncology Department, Instituto Valenciano de Oncologia, 46009 Valencia, Spain.

Ana Vivancos (A)

Cancer Genomics Lab, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.

Classifications MeSH